Timing of development of measles-specific immunoglobulin M and G after primary measles vaccination

RF Helfand, S Kebede, HE Gary Jr… - Clinical Diagnostic …, 1999 - Am Soc Microbiol
ABSTRACT A standard method for diagnosing measles is to detect measles-specific
immunoglobulin M (IgM) in the serum of infected persons. Interpreting a positive IgM result …

Measles immunity in children vaccinated before one year of age

A Schluederberg, SH Lamm… - American journal of …, 1973 - academic.oup.com
Abstract Schluederberg, A.(Yale University School of Medicine, New Haven, Conn. 06510),
SH Lamm, PJ Landrigan, and FL Black. Measles immunity in children vaccinated before one …

Measles vaccine: immunity, reinfection and revaccination.

CCJ Linnemann - 1973 - cabidigitallibrary.org
This is a survey of the epidemiology of measles in the face of new patterns of immunity
produced by measles vaccination. Live vaccine is highly effective, except perhaps in …

Poor serologic responses five to seven years after immunization with high and standard titer measles vaccines

H Whittle, P Aaby, B Samb, B Cisse… - The Pediatric …, 1999 - journals.lww.com
Background. Few data exist on the persistence of measles antibodies after vaccination of
West African infants. Therefore we examined measles antibody titers 5 to 7 years after …

Booster vaccination with further live attenuated measles vaccine

JW Bass, SB Halstead, GW Fischer, JK Podgore… - JAMA, 1976 - jamanetwork.com
Revaccination with live attenuated measles vaccine was evaluated in a large group of
children to determine (1) if protective antibody to measles infection could be augmented and …

Studies on immunity to measles

S Krugman, JP Giles, H Friedman, S Stone - The Journal of pediatrics, 1965 - Elsevier
Studies on immunity to measles have been in progress since 1960. Primary infection with
measles virus was followed by evidence of detectable antibody by the twelfth day; peak …

Measles antibody in vaccinated human immunodeficiency virus type 1-infected children

SM Arpadi, LE Markowitz, AL Baughman, K Shah… - …, 1996 - publications.aap.org
Objectives. The goals of this study were to evaluate the proportion of previously vaccinated
human immunodeficiency virus (HIV) type 1-infected children with detectable …

Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months

HA Gans, AM Arvin, J Galinus, L Logan, R DeHovitz… - Jama, 1998 - jamanetwork.com
Context.—Measles causes serious morbidity in infants, with the highest risk among those
who are 6 to 12 months of age. In the United States, measles vaccine has been given at age …

[PDF][PDF] Further attenuated live measles vaccines: the need for revised recommendations

RD Krugman, R Rosenberg, K McIntosh… - The Journal of …, 1977 - academia.edu
RECENTLY MODIFIED RECOMMENDATIONS 1'~ for the use of live attenuated measles
vaccines call for routine immunization of children at 15 months of age or older. During …

Surveillance of antibody to measles, mumps, and rubella by age.

P Morgan-Capner, J Wright, CL Miller, E Miller - British medical journal, 1988 - bmj.com
Before the introduction of measles, mumps, and rubella vaccine a survey was carried out to
measure antibody prevalence to the three viruses by age. A total of 8716 samples of serum …